Anti-BCA-225

Y300311 by Applied Biological Materials Inc. (ABM) is a mouse monoclonal antibody targeting BCA-225, a breast carcinoma-associated glycoprotein (220–225 kDa) raised against the T47D human breast carcinoma cell line. Suited for research into breast carcinoma tumor antigen expression. Consult the lot-specific certificate of analysis for confirmed working applications and dilutions.